Market Cap 210.95M
Revenue (ttm) 28.52M
Net Income (ttm) -40.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -140.88%
Debt to Equity Ratio 0.00
Volume 74,600
Avg Vol 156,336
Day's Range N/A - N/A
Shares Out 7.67M
Stochastic %K 57%
Beta 0.60
Analysts Strong Sell
Price Target $38.20

Company Profile

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 509 4583
Address:
Two Tower Place, 7th Floor, South San Francisco, United States
havivi77
havivi77 Oct. 24 at 8:31 PM
$ASMB accumulation is still on going… explosion has not happened yet…
0 · Reply
Dachshundtrader
Dachshundtrader Oct. 24 at 5:08 PM
$ASMB up ~8% on almost no volume today. Not hype, not noise — just what happens when a tiny float meets a bit of quiet accumulation. Sometimes the calmest days say the most. $GILD
0 · Reply
Jkwran69
Jkwran69 Oct. 21 at 7:49 PM
$ASMB did something negative happen at their investment conference today?
1 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 2:35 PM
$RANI $ASMB $QNRX $QURE $IMRX But let's take it a step farther... RANI pre-funded warrants 82 million @ $.48 and exercisable at $.0001 ASMB pre funded warrants Class A + B prefunded warrants at $19.60 below the $21.60 offer price QNRX pre funded warrants This is a nightmare. Series H, I, J, K prefunded warrants for $88 million QURE pre funded warrants 526K @$47.50 and exercisable at $.0001 IMRX pre funded warrants on 8/21 as part of $25 mil PP (secret investor) at $3.95, with option in at $5.50. Stock walks 4.70 to new highs $10+. Then another round on 9/25 with Sanofi $25 mil PP at $9.23 on the heels of "extroardinary" results per the company. For this one, stock more than doubles on a $25 mil private placement to unknown investor. Then a month later they announce another $25 mil private placement from Sanofi and stock drops 40%. Who really knows anything at this point!
0 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 11:44 AM
Let's look at the biotech landscape: $RANI Licensing deal Fri w/Chugai ($CHGCY). $60 mil PIPE w/pre-funded warrants. Up 250%. No trial results $ASMB (Hep B+D) 8/25 announces 94% reduction in Hep at 350 mil dose. Announces $175 mil offer at $19.60 with Gilead separate $45 mil at $19.60. Never went red. New 52 highs Fri @ $30.20 $QNRX (Netherton -extremely rare) No trial news. Announces PP on 10/10 in $7's. Stock runs to $41. Now $16's. Up more than 100% $QURE (Huntingtons - extremely rare) on 9/24 announces some trial progression for AMT-130. Stock runs $13's to $50 . Immed announce $200 mil offering. Upsized to $350 mil. Stock hits new 52's last wk $64. $IMRX (Pancreatic cancer) On 9/25 announces world's best survival rate at 6 mos of 94%. Further announcing survival rate of 86% at 9 mos vs. only FDA approved 42% in the market. Announces $175 mil offering with PP from Sanofi $25 mil. Identical to ASMB. Offering & placement @ $9.23 (no discount). Stock now $5.58
1 · Reply
Poldi2021
Poldi2021 Oct. 17 at 4:17 PM
$ASMB $BCAB that is funny. I did exactly the other way round. ASMB has too much potential…good 1b results and the Next rocket leaves
1 · Reply
onemillion2012
onemillion2012 Oct. 17 at 3:17 PM
$ASMB decreased my holdings. Bought more of $BCAB
1 · Reply
Dachshundtrader
Dachshundtrader Oct. 15 at 4:40 PM
$ASMB – today’s S-3 doesn’t signal selling. It simply registers GILD’s existing holdings so they could be sold later if needed. No new shares, no dilution — and no indication $GILD plans to reduce its stake.
0 · Reply
Poldi2021
Poldi2021 Oct. 15 at 3:41 PM
$ASMB I try to figure out what that means/ the purpose is?!
0 · Reply
onemillion2012
onemillion2012 Oct. 15 at 3:37 PM
$ASMB nobody talking about the S3 Filling last night. That Gilead is selling it's entire post over 29 percent of the outstanding float. For a maximum price at $24,84 Any thoughts
0 · Reply
Latest News on ASMB
havivi77
havivi77 Oct. 24 at 8:31 PM
$ASMB accumulation is still on going… explosion has not happened yet…
0 · Reply
Dachshundtrader
Dachshundtrader Oct. 24 at 5:08 PM
$ASMB up ~8% on almost no volume today. Not hype, not noise — just what happens when a tiny float meets a bit of quiet accumulation. Sometimes the calmest days say the most. $GILD
0 · Reply
Jkwran69
Jkwran69 Oct. 21 at 7:49 PM
$ASMB did something negative happen at their investment conference today?
1 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 2:35 PM
$RANI $ASMB $QNRX $QURE $IMRX But let's take it a step farther... RANI pre-funded warrants 82 million @ $.48 and exercisable at $.0001 ASMB pre funded warrants Class A + B prefunded warrants at $19.60 below the $21.60 offer price QNRX pre funded warrants This is a nightmare. Series H, I, J, K prefunded warrants for $88 million QURE pre funded warrants 526K @$47.50 and exercisable at $.0001 IMRX pre funded warrants on 8/21 as part of $25 mil PP (secret investor) at $3.95, with option in at $5.50. Stock walks 4.70 to new highs $10+. Then another round on 9/25 with Sanofi $25 mil PP at $9.23 on the heels of "extroardinary" results per the company. For this one, stock more than doubles on a $25 mil private placement to unknown investor. Then a month later they announce another $25 mil private placement from Sanofi and stock drops 40%. Who really knows anything at this point!
0 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 11:44 AM
Let's look at the biotech landscape: $RANI Licensing deal Fri w/Chugai ($CHGCY). $60 mil PIPE w/pre-funded warrants. Up 250%. No trial results $ASMB (Hep B+D) 8/25 announces 94% reduction in Hep at 350 mil dose. Announces $175 mil offer at $19.60 with Gilead separate $45 mil at $19.60. Never went red. New 52 highs Fri @ $30.20 $QNRX (Netherton -extremely rare) No trial news. Announces PP on 10/10 in $7's. Stock runs to $41. Now $16's. Up more than 100% $QURE (Huntingtons - extremely rare) on 9/24 announces some trial progression for AMT-130. Stock runs $13's to $50 . Immed announce $200 mil offering. Upsized to $350 mil. Stock hits new 52's last wk $64. $IMRX (Pancreatic cancer) On 9/25 announces world's best survival rate at 6 mos of 94%. Further announcing survival rate of 86% at 9 mos vs. only FDA approved 42% in the market. Announces $175 mil offering with PP from Sanofi $25 mil. Identical to ASMB. Offering & placement @ $9.23 (no discount). Stock now $5.58
1 · Reply
Poldi2021
Poldi2021 Oct. 17 at 4:17 PM
$ASMB $BCAB that is funny. I did exactly the other way round. ASMB has too much potential…good 1b results and the Next rocket leaves
1 · Reply
onemillion2012
onemillion2012 Oct. 17 at 3:17 PM
$ASMB decreased my holdings. Bought more of $BCAB
1 · Reply
Dachshundtrader
Dachshundtrader Oct. 15 at 4:40 PM
$ASMB – today’s S-3 doesn’t signal selling. It simply registers GILD’s existing holdings so they could be sold later if needed. No new shares, no dilution — and no indication $GILD plans to reduce its stake.
0 · Reply
Poldi2021
Poldi2021 Oct. 15 at 3:41 PM
$ASMB I try to figure out what that means/ the purpose is?!
0 · Reply
onemillion2012
onemillion2012 Oct. 15 at 3:37 PM
$ASMB nobody talking about the S3 Filling last night. That Gilead is selling it's entire post over 29 percent of the outstanding float. For a maximum price at $24,84 Any thoughts
0 · Reply
havivi77
havivi77 Oct. 14 at 7:35 PM
0 · Reply
HighReturnStocks
HighReturnStocks Oct. 14 at 5:47 PM
$ASMB another banger, still holding all. You all like all these plays like $WKEY. Im also eyeing $CAMP and $CLPS for big gains.
0 · Reply
Dachshundtrader
Dachshundtrader Oct. 14 at 5:23 PM
$ASMB heating up again 🔥 At this pace, $GILD better hurry if they still want the “discount version” 😏 Every green candle makes that buyout a little more expensive 💸
0 · Reply
HighReturnStocks
HighReturnStocks Oct. 14 at 2:40 PM
$CAMP Loved the dip today, grabbed another chunk to my swing $DRMA still holding $ASMB swinging this till we see $30+
0 · Reply
Spiderman77
Spiderman77 Oct. 14 at 1:39 PM
$ASMB Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will participate in fireside chats at two upcoming investor conferences. H.C. Wainwright Liver Disease Virtual Conference Anuj Gaggar, MD, PhD, chief medical officer, will present in a pre-recorded fireside chat that will be available on demand during the H.C. Wainwright Liver Disease Virtual Conference starting at 7 a.m. Eastern Time on October 21, 2025. Guggenheim 2nd Annual Healthcare Innovation Conference Jason Okazaki, chief executive officer and president, and Dr. Gaggar will present in a fireside chat during the Guggenheim 2nd Annual Healthcare Innovation Conference at 11 a.m. Eastern Time on November 12, 2025.
0 · Reply
onemillion2012
onemillion2012 Oct. 14 at 11:48 AM
$ASMB Onemillion2012 updates rating for Assembly Biosciences ( $ASMB ) to strong Buy, target set at $84$96
0 · Reply
SearchFor911
SearchFor911 Oct. 14 at 11:18 AM
$ASMB $GILD more data incoming in fall 2025. more value incoming 🚀.
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 11:17 AM
HC Wainwright & Co. has adjusted their stance on Assembly Biosciences ( $ASMB ), setting the rating to Buy with a target price of 50.
0 · Reply
DangerDolan
DangerDolan Oct. 13 at 7:24 PM
0 · Reply
GimliSonofGloin
GimliSonofGloin Oct. 10 at 12:06 PM
$ASMB https://www.stocktitan.net/news/ASMB/assembly-biosciences-presents-interim-phase-1b-data-for-hsv-helicase-7b2ukzyx72tp.html
0 · Reply
Timefortendies77
Timefortendies77 Oct. 9 at 8:08 PM
$ASMB 1 month data soon?
0 · Reply
Zonata
Zonata Oct. 8 at 9:33 PM
$ASMB this is primed to break into the 30... imo we'll test 35-38 before EOY. GL to all, and let's hope for a big buyout.
2 · Reply